Apitoria Pharma Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is IBANDRONATE SODIUM (NON-STERILE DRUG SUBSTANCE), with a corresponding US DMF Number 20393.
Remarkably, this DMF maintains an Active status since its submission on March 29, 2007, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 10, 2013, and payment made on January 04, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II